ACCOMPLISH
2008
Avoiding Cardiovascular Events through Combination Therapy in Patients Living with Systolic Hypertension
In 11,506 high-risk patients with hypertension, an ACE inhibitor plus amlodipine reduced cardiovascular events compared with an ACE inhibitor plus hydrochlorothiazide.
Result
Efficacy: CV death, MI, stroke and related eventsHR 0.8
Below 1 favours ACE inhibitor plus amlodipine, above 1 favours an ACE inhibitor plus hydrochlorothiazide.
- Absolute difference
- 2.2 points
The absolute difference is derived from the event rates.
- Subtopic
- Drug class
- Design
- Double-blind RCT, stopped early
- Relevance
- Important: one of several pillars.
- Cited in
- ESC 2021 Prevention
- Source
- Jamerson K, et al. N Engl J Med. 2008;359(23):2417-2428.doi 10.1056/NEJMoa0806182
Discussion & critique
Challenged thiazide-based combinations. Used hydrochlorothiazide rather than chlorthalidone, and the office-BP equivalence between arms complicates interpretation.